Discovery of oral-available resveratrol-caffeic acid based hybrids inhibiting acetylated and phosphorylated STAT3 protein.

MLA

Li, Shanshan, et al. “Discovery of Oral-Available Resveratrol-Caffeic Acid Based Hybrids Inhibiting Acetylated and Phosphorylated STAT3 Protein.” European Journal of Medicinal Chemistry, vol. 124, Nov. 2016, pp. 1006–18. EBSCOhost, https://doi.org/10.1016/j.ejmech.2016.10.028.

APA

Li, S., Zhang, W., Yang, Y., Ma, T., Guo, J., Wang, S., Yu, W., & Kong, L. (2016). Discovery of oral-available resveratrol-caffeic acid based hybrids inhibiting acetylated and phosphorylated STAT3 protein. European Journal of Medicinal Chemistry, 124, 1006–1018. https://doi.org/10.1016/j.ejmech.2016.10.028

Chicago

Li, Shanshan, Wenda Zhang, Yanwei Yang, Ting Ma, Jianpeng Guo, Shanshan Wang, Wenying Yu, and Lingyi Kong. 2016. “Discovery of Oral-Available Resveratrol-Caffeic Acid Based Hybrids Inhibiting Acetylated and Phosphorylated STAT3 Protein.” European Journal of Medicinal Chemistry 124 (November): 1006–18. doi:10.1016/j.ejmech.2016.10.028.